Michael Hofman

Mechanistic Insights for Optimizing PSMA Radioligand Therapy.

Aravind S Ravi Kumar, Michael S Hofman

Journal article  |  2020  |  Clinical Cancer Research

PSMA radioligand therapy is a promising new class of therapy for prostate cancer. Heterogeneity of PSMA expression is an important..

Technical Note: Rapid multiexponential curve fitting algorithm for voxel-based targeted radionuclide dosimetry

Price Jackson, Lachlan McIntosh, Michael S Hofman, Grace Kong, Rodney J Hicks

Journal article  |  2020  |  Medical Physics

BACKGROUND: Dosimetry in nuclear medicine often relies on estimating pharmacokinetics based on sparse temporal data. As analysis m..

Long-Term Follow-up and Outcomes of Retreatment in an Expanded 50-Patient Single-Center Phase II Prospective Trial of Lu-177-PSMA-617 Theranostics in Metastatic Castration-Resistant Prostate Cancer

John Violet, Shahneen Sandhu, Amir Iravani, Justin Ferdinandus, Thang Sue-Ping, Grace Kong, Aravind Ravi Kumar, Tim Akhurst, David Pattison, Alexis Beaulieu, Jennifer Mooi, Ben Tran, Christina Guo, Victor Kalff, Declan G Murphy, Price Jackson, Peter Eu, Mark Scalzo, Scott G Williams, Rod J Hicks, et al.

Journal article  |  2020  |  Journal of Nuclear Medicine

177Lu-PSMA-617 is a radioligand with high affinity for prostate-specific membrane antigen (PSMA), enabling targeted β-irradiation ..

ProPSMA: A Callout to the Nuclear Medicine Community to Change Practices with Prospective, High-Quality Data

Michael S Hofman

Journal article  |  2020  |  Journal of Nuclear Medicine

Early Outcomes of Surgery for Carcinoid Heart Disease

Matthew S Yong, Grace Kong, Prakash Ludhani, Michael Michael, John Morgan, Michael S Hofman, Rodney J Hicks, Marco Larobina

Journal article  |  2020  |  Heart, Lung and Circulation

BACKGROUND: The prognosis of patients with metastatic neuroendocrine neoplasms (NEN) continues to improve with modern oncological ..

FDG PET/CT for tumoral and systemic immune response monitoring of advanced melanoma during first-line combination ipilimumab and nivolumab treatment

Amir Iravani, Medhat M Osman, Alison M Weppler, Roslyn Wallace, Anna Galligan, Arian Lasocki, Morgan O Hunter, Tim Akhurst, Michael S Hofman, Peter KH Lau, Damien Kee, George Au-Yeung, Shahneen Sandhu, Rodney J Hicks

Journal article  |  2020  |  European Journal of Nuclear Medicine and Molecular Imaging

PURPOSE: We aimed to investigate the role of FDG-PET/CT in monitoring of response and immune-related adverse events (irAEs) follow..

Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study

Michael S Hofman, Nathan Lawrentschuk, Roslyn J Francis, Colin Tang, Ian Vela, Paul Thomas, Natalie Rutherford, Jarad M Martin, Mark Frydenberg, Ramdave Shakher, Lih-Ming Wong, Kim Taubman, Sze Ting Lee, Edward Hsiao, Paul Roach, Michelle Nottage, Ian Kirkwood, Dickon Hayne, Emma Link, Petra Marusic, et al.

Journal article  |  2020  |  The Lancet

BACKGROUND: Conventional imaging using CT and bone scan has insufficient sensitivity when staging men with high-risk localised pro..

Gallium-68 Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer-Updated Diagnostic Utility, Sensitivity, Specificity, and Distribution of Prostate-specific Membrane Antigen-avid Lesions: A Systematic Review and Meta-analysis

Marlon Perera, Nathan Papa, Matthew Roberts, Michael Williams, Cristian Udovicich, Ian Vela, Daniel Christidis, Damien Bolton, Michael S Hofman, Nathan Lawrentschuk, Declan G Murphy

Journal article  |  2020  |  European Urology

CONTEXT: Accurate staging of high-risk localised, advanced, and metastatic prostate cancer is becoming increasingly more important..

Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019

Silke Gillessena, Gerhardt Attard, Tomasz M Beer, Himisha Beltran, Anders Bjartell, Alberto Bossi, Alberto Briganti, Rob G Bristow, Kim N Chi, Noel Clarke, Ian D Davis, Johann de Bono, Charles G Drake, Ignacio Duran, Ros Eeles, Eleni Efstathiou, Christopher P Evans, Stefano Fanti, Felix Y Feng, Karim Fizazi, et al.

Journal article  |  2020  |  European Urology

BACKGROUND: Innovations in treatments, imaging, and molecular characterisation in advanced prostate cancer have improved outcomes,..

Abscopal Regressions of Lymphoma After Involved-Site Radiation Therapy Confirmed by Positron Emission Tomography.

Michael P MacManus, Michael S Hofman, Rodney J Hicks, Belinda A Campbell, Andrew Wirth, John F Seymour, Nicole Haynes, Kate Burbury

Journal article  |  2020  |  International Journal of Radiation Oncology*Biology*Physics

PURPOSE: Patients with abscopal regressions of lymphoma after palliative involved-site radiation therapy (ISRT), detected on seque..

Prognostic biomarkers in men with metastatic castration-resistant prostate cancer receiving [177Lu]-PSMA-617.

Justin Ferdinandus, John Violet, Shahneen Sandhu, Rodney J Hicks, Aravind S Ravi Kumar, Amir Iravani, Grace Kong, Tim Akhurst, Sue Ping Thang, Declan G Murphy, Scott Williams, Michael S Hofman

Journal article  |  2020  |  European Journal of Nuclear Medicine and Molecular Imaging

PURPOSE: We analysed quantitative biomarkers derived from both baseline whole-body imaging and blood serum to identify prognostic ..

Lutetium-177 prostate-specific membrane antigen (PSMA) theranostics: practical nuances and intricacies

Amir Iravani, John Violet, Arun Azad, Michael S Hofman

Journal article  |  2020  |  Prostate Cancer and Prostatic Diseases

Theranostic principles utilize a molecular biomarker specific for a tumor target, initially for imaging to assess target expressio..

Correlation between percutaneous biopsy and final histopathology for retroperitoneal sarcoma: a single-centre study

Rebekah Young, Hayden Snow, Shona Hendry, Catherine Mitchell, John Slavin, Stephen Schlicht, Lumine Na, Michael S Hofman, David E Gyorki

Journal article  |  2020  |  ANZ Journal of Surgery

Protocol for the PRIMARY clinical trial, a prospective, multicentre, cross-sectional study of the additive diagnostic value of gallium-68 prostate-specific membrane antigen positron-emission tomography/computed tomography to multiparametric magnetic resonance imaging in the diagnostic setting for men being investigated for prostate cancer

Amer Amin, Alexandar Blazevski, James Thompson, Matthijs J Scheltema, Michael S Hofman, Declan Murphy, Nathan Lawrentschuk, Niranjan Sathianathen, Jada Kapoor, Henry H Woo, Venu Chalasani, Krishan Rasiah, Pim J van Leeuwen, Reuben Tang, Thomas Cusick, Phillip Stricker, Louise Emmett

Journal article  |  2020  |  BJU International

OBJECTIVES: Primary objectives: To determine the additive value of gallium-68 prostate-specific membrane antigen (PSMA) positron e..

Expanding the role of small-molecule PSMA ligands beyond PET staging of prostate cancer

Shankar Siva, Cristian Udovicich, Ben Tran, Homi Zargar, Declan G Murphy, Michael S Hofman

Journal article  |  2020  |  Nature Reviews Urology

Prostate-specific membrane antigen (PSMA) positron emission tomography (PET) is rapidly being established as arguably the leading ..

Prostate Specific Membrane Antigen Targeted Positron Emission Tomography of Primary Prostate Cancer: Assessing Accuracy with Whole Mount Pathology

Louise Emmett, Michael S Hofman

Journal article  |  2020  |  Journal of Urology

Prostate-Specific Membrane Antigen Ligand Positron Emission Tomography in Men with Nonmetastatic Castration-Resistant Prostate Cancer

Wolfgang P Fendler, Manuel Weber, Amir Iravani, Michael S Hofman, Jeremie Calais, Johannes Czernin, Harun Ilhan, Fred Saad, Eric J Small, Matthew R Smith, Paola M Perez, Thomas A Hope, Isabel Rauscher, Anil Londhe, Angela Lopez-Gitlitz, Shinta Cheng, Tobias Maurer, Ken Herrmann, Matthias Eiber, Boris Hadaschik

Journal article  |  2019  |  Clinical Cancer Research

PURPOSE: Systemic androgen-signaling inhibition added to ongoing androgen-deprivation therapy (ADT) improved clinical outcomes in ..

Radiation Dosimetry in 177Lu-PSMA-617 Therapy Using a Single Post-treatment SPECT/CT: A Novel Methodology to Generate Time- and Tissue-specific Dose Factors.

Price A Jackson, Michael S Hofman, Rodney J Hicks, Mark Scalzo, John A Violet

Journal article  |  2019  |  Journal of Nuclear Medicine

Calculation of radiation dosimetry in targeted nuclear medicine therapies is traditionally resource-intensive requiring multiple p..

Peptide Receptor Radionuclide Therapy (PRRT) Appears to be Ineffective Therapy for Tumor-Induced Osteomalacia (TIO)

Iris R Hartley, Damian Wild, Michael S Hofman, John W Delahunt, Michael T Collins, Rachel I Gafni

Conference Proceedings  |  2019  |  JOURNAL OF BONE AND MINERAL RESEARCH

The Role of 68Ga-DOTA-Octreotate PET/CT in Follow-Up of SDH-Associated Pheochromocytoma and Paraganglioma

Grace Kong, Tess Schenberg, Christopher J Yates, Alison Trainer, Nirupa Sachithanandan, Amir Iravani, Aravind Ravi Kumar, Michael S Hofman, Tim Akhurst, Michael Michael, Rodney J Hicks

Journal article  |  2019  |  The Journal of Clinical Endocrinology & Metabolism

Purpose: Germline succinate dehydrogenase (SDHx) mutation carriers, especially SDHB, are at increased risk for malignancy and requ..

The role of prostate-specific membrane antigen PET/computed tomography in primary staging of prostate cancer

Samantha Koschel, Declan G Murphy, Michael S Hofman, Lih-Ming Wong

Journal article  |  2019  |  Current Opinion in Urology

PURPOSE OF REVIEW: Functional imaging with PET combined with computed tomography (CT) is of emerging interest in prostate cancer (..

A Novel Application of [F-18]Fluorothymidine-PET ([F-18]FLT-PET) in Clinical Practice to Quantify Regional Bone Marrow Function in a Patient With Treatment-Induced Cytopenias and to Guide "Marrow-Sparing" Radiotherapy

Belinda A Campbell, Michael S Hofman, H Miles Prince

Journal article  |  2019  |  Clinical Nuclear Medicine

F-Fluorothymidine-positron emission tomography with CT fusion ([F]FLT-PET/CT) offers a unique and non-invasive method for three-di..

Poor Outcomes for Patients with Metastatic Castration-resistant Prostate Cancer with Low Prostate-specific Membrane Antigen (PSMA) Expression Deemed Ineligible for 177Lu-labelled PSMA Radioligand Therapy

Sue Ping Thang, John Violet, Shahneen Sandhu, Amir Iravani, Tim Akhurst, Grace Kong, Aravind Ravi Kumar, Declan G Murphy, Scott G Williams, Rodney J Hicks, Michael S Hofman

Journal article  |  2019  |  European Urology Oncology

BACKGROUND: Prostate-specific membrane antigen (PSMA) is overexpressed in metastatic castration-resistant prostate cancer (mCRPC) ..

What is the best PET target for early biochemical recurrence of prostate cancer?

Jeremie Calais, Francesco Ceci, Matthias Eiber, Thomas A Hope, Michael S Hofman, Christoph Rischpler, Tore Bach-Gansmo, Wolfgang P Fendler, Johannes Czernin

Journal article  |  2019  |  The Lancet Oncology

Mitogen-Activated Protein Kinase Pathway Inhibition for Redifferentiation of Radioiodine Refractory Differentiated Thyroid Cancer: An Evolving Protocol

Amir Iravani, Benjamin Solomon, David A Pattison, Price Jackson, Aravind Ravi Kumar, Grace Kong, Michael S Hofman, Tim Akhurst, Rodney J Hicks

Journal article  |  2019  |  Thyroid

Background: Some patients with metastatic differentiated thyroid cancer (DTC) lack iodine avidity and are the..

TheraP: a randomized phase 2 trial of Lu-177-PSMA-617 theranostic treatment vs cabazitaxel in progressive metastatic castration-resistant prostate cancer (Clinical Trial Protocol ANZUP 1603)

Michael S Hofman, Louise Emmett, John Violet, Alison Y Zhang, Nicola J Lawrence, Martin Stockler, Roslyn J Francis, Amir Iravani, Scott Williams, Arun Azad, Andrew Martin, Margaret McJannett, Ian D Davis

Journal article  |  2019  |  BJU International

OBJECTIVE: To assess the activity and safety of cabazitaxel chemotherapy vs that of treatment with 177 Lu-PSMA-617, a novel radiol..

Partial volume corrected image derived input functions for kinetic modelling of FDG PET brain studies

H Keijzers, SSV Golla, M Yaqub, N Scheltens, P Scheltens, M Hofman, R Boellaard

Conference Proceedings  |  2019  |  EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Tumour Heterogeneity and Resistance to Therapy in Prostate Cancer: A Fundamental Limitation of Prostate-specific Membrane Antigen Theranostics or a Key Strength?

Michael S Hofman, Louise Emmett

Journal article  |  2019  |  European Urology

Prostate-Specific Membrane Antigen Positron-Emission Tomography (PSMA-PET) in High-Risk Nonmetastatic Castration-Resistant Prostate Cancer (nmCRPC) SPARTAN-like Patients Negative by Conventional Imaging

W Fendler, M Weber, A Iravani, MS Hofman, J Calais, J Czernin, H Ilhan, F Saad, EJ Small, MR Smith, PM Perez, A Hope, I Rauscher, A Londhe, A Lopez-Gitlitz, S Cheng, T Maurer, K Herrmann, B Hadaschik, M Eiber

Conference Proceedings  |  2019  |  EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Role of PET/CT in multimodality imaging in differentiating cardiac sarcoidosis from arrhythmogenic right ventricular dysplasia

Cheng Yee Goh, Adam Gay, Michael S Hofman, Chiew Wong, James Westcott, Nathan Better

Journal article  |  2019  |  Journal of Nuclear Cardiology

A Self-Fulfilling Prophecy: Comparing Lu-177-PSMA Radioligand Therapy in Taxane-Naive Versus Posttaxane Metastasized Prostate Cancer Patients?

Kambiz Rahbar, Michael S Hofman, Andres J Schrader, Martin Boegemann

Journal article  |  2019  |  Journal of Nuclear Medicine

NaF PET/CT for response assessment of prostate cancer bone metastases treated with single fraction stereotactic ablative body radiotherapy

Nicholas Hardcastle, Michael S Hofman, Ching-Yu Lee, Jason Callahan, Lisa Selbie, Farshad Foroudi, Mark Shaw, Sarat Chander, Andrew Lim, Brent Chesson, Declan G Murphy, Tomas Kron, Shankar Siva

Journal article  |  2019  |  Radiation Oncology

Importance of timing in staging head and neck cancer: cervical adenopathy post-tonsillectomy mimicking malignancy

Nicholas W Bucknell, Ben J Dixon, Michael S Hoffman, Lachlan J McDowell

Journal article  |  2019  |  ANZ Journal of Surgery

Guiding management of therapy in prostate cancer: time to switch from conventional imaging to PSMA PET?

Ramin Alipour, Arun Azad, Michael S Hofman

Journal article  |  2019  |  Therapeutic Advances in Medical Oncology

F-18-fluciclovine PET-CT and Ga-68-PSMA-11 PET-CT in patients with early biochemical recurrence after prostatectomy: a prospective, single-centre, single-arm, comparative imaging trial

Jeremie Calais, Francesco Ceci, Matthias Eiber, Thomas A Hope, Michael S Hofman, Christoph Rischpler, Tore Bach-Gansmo, Cristina Nanni, Bital Savir-Baruch, David Elashoff, Tristan Grogan, Magnus Dahlbom, Roger Slavik, Jeannine Gartmann, Kathleen Nguyen, Vincent Lok, Hossein Jadvar, Amar U Kishan, Matthew B Rettig, Robert E Reiter, et al.

Journal article  |  2019  |  The Lancet Oncology

Characteristics and outcomes of therapy-related myeloid neoplasms after peptide receptor radionuclide/chemoradionuclide therapy (PRRT/PRCRT) for metastatic neuroendocrine neoplasia: a single-institution series

Isaac Goncalves, Kate Burbury, Michael Michael, Amir Iravani, Aravind S Ravi Kumar, Tim Akhurst, Ing S Tiong, Piers Blombery, Michael S Hofman, David Westerman, Rodney J Hicks, Grace Kong

Journal article  |  2019  |  European Journal of Nuclear Medicine and Molecular Imaging

PET-detected pneumonitis following curative-intent chemoradiation in non-small cell lung cancer (NSCLC): recognizing patterns and assessing the impact on the predictive ability of FDG-PET/CT response assessment

Amir Iravani, Guy-Anne Turgeon, Tim Akhurst, Jason W Callahan, Mathias Bressel, Sarah J Everitt, Shankar Siva, Michael S Hofman, Rodney J Hicks, David L Ball, Michael P Mac Manus

Journal article  |  2019  |  European Journal of Nuclear Medicine and Molecular Imaging

Going nuclear: it is time to embed the nuclear medicine physician in the prostate cancer multidisciplinary team

Declan G Murphy, Michael S Hofman, Arun Azad, John Violet, Rodney J Hicks, Nathan Lawrentschuk

Journal article  |  2019  |  BJU International

Detection and localisation of primary prostate cancer using 68 Ga-PSMA PET/CT compared with mpMRI and radical prostatectomy specimens.

Arveen A Kalapara, Tatenda Nzenza, Henry Yc Pan, Zita Ballok, Shakher Ramdave, Richard O'Sullivan, Andrew Ryan, Martin Cherk, Michael S Hofman, Badrinath R Konety, Nathan Lawrentschuk, Damien Bolton, Declan G Murphy, Jeremy P Grummet, Mark Frydenberg

Journal article  |  2019  |  BJU International

OBJECTIVE: To compare the accuracy of 68 Gallium prostate-specific membrane antigen positron emission tomography/computed tomograp..

Independent and incremental value of ventilation/perfusion PET/CT and CT pulmonary angiography for pulmonary embolism diagnosis: results of the PECAN pilot study

Pierre-Yves Le Roux, Amir Iravani, Jason Callahan, Kate Burbury, Peter Eu, Daniel P Steinfort, Eddie Lau, Beverly Woon, Pierre-Yves Salaun, Rodney J Hicks, Michael S Hofman

Journal article  |  2019  |  European Journal of Nuclear Medicine and Molecular Imaging

PSMA PET applications in the prostate cancer journey: from diagnosis to theranostics

RS Eapen, TC Nzenza, DG Murphy, MS Hofman, M Cooperberg, N Lawrentschuk

Journal article  |  2019  |  World Journal of Urology

Use of PSMA PET/CT to Assess Treatment Response Following Upfront Chemohormonal Therapy in Metastatic Prostate Cancer (MPC)

Angelyn Anton, Olfat Kamel Hasan, Zita Ballok, Patrick Bowden, Tony Costello, Laurence Harewood, Niall Corcoran, Phil Dundee, Justin Peters, Nathan Lawrentschuk, Andrew Troy, David Webb, Yee Chan, Andrew See, Shankar Siva, Declan Murphy, Michael S Hofman, Ben Tran

Conference Proceedings  |  2019  |  ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY

Cu-64-SARTATE PET Imaging of Patients with Neuroendocrine Tumors Demonstrates High Tumor Uptake and Retention, Potentially Allowing Prospective Dosimetry for Peptide Receptor Radionuclide Therapy

Rodney J Hicks, Price Jackson, Grace Kong, Robert E Ware, Michael S Hofman, David A Pattison, Timothy A Akhurst, Elizabeth Drummond, Peter Roselt, Jason Callahan, Roger Price, Charmaine M Jeffery, Emily Hong, Wayne Noonan, Alan Herschtal, Lauren J Hicks, Amos Hedt, Matthew Harris, Brett M Paterson, Paul S Donnelly

Journal article  |  2019  |  Journal of Nuclear Medicine

Voxel-wise correlation of positron emission tomography/computed tomography with multiparametric magnetic resonance imaging and histology of the prostate using a sophisticated registration framework

Hayley M Reynolds, Scott Williams, Price Jackson, Catherine Mitchell, Michael S Hofman, Rodney J Hicks, Declan G Murphy, Annette Haworth

Journal article  |  2019  |  BJU International

Prostate-specific Membrane Antigen Across the Spectrum of Prostate Cancer: Detection, Surgery, and Theranostics

Declan G Murphy, Arun A Azad, Shahneen Sandhu, John Violet, Michael S Hofman

Journal article  |  2019  |  European Urology

The role of F-18-FDG-PET/CT in evaluating retroperitoneal masses -Keeping your eye on the ball!

Te-Jui Hung, Luke McLean, Catherine Mitchell, Claire Pascoe, Nathan Lawrentschuk, Declan G Murphy, Amir Iravani, Dalveer Singh, Michael S Hofman, Lamiaa Zidan, Tim Akhurst, Jeremy Lewin, Rodney J Hicks

Journal article  |  2019  |  Cancer Imaging

Prospective head-to-head comparative phase 3 study between F-18-fluciclovine and Ga-68-PSMA-11 PET/CT in patients with early biochemical recurrence of prostate cancer.

Jeremie Calais, Francesco Ceci, Matthias Eiber, Tore Bach-Gansmo, Cristina Nanni, Bital Savir-Baruch, Michael Hofman, Tom Hope, Christoph Rischpler, David Elashoff, Tristan Grogan, Magnus Dahlbom, Roger Slavik, Jeannine Gartmann, Robert Evan Reiter, Matthew Rettig, Hossein Jadvar, Wolfgang P Fendler, Johannes Czernin

Conference Proceedings  |  2019  |  Journal of Clinical Oncology

Intra-individual comparison of Ga-68-PSMA-11 and F-18-DCFPyL normal-organ biodistribution

Goncalo Ferreira, Amir Iravani, Michael S Hofman, Rodney J Hicks

Journal article  |  2019  |  Cancer Imaging

Independent and incremental value of Ventilation/Perfusion PET/CT and CT pulmonary angiography for pulmonary embolism diagnosis: results of the PECAN pilot study

Pierre Yves Le Roux, Amir Iravani, Jason Callahan, Kate Burbury, Peter Eu, Daniel Steinfort, Eddie Lau, Pierre Salaun, Rodney Hicks, Michael Hofman

Conference Proceedings  |  2019  |  JOURNAL OF NUCLEAR MEDICINE

Ga-68-PSMA-11 PET/CT detects prostate cancer at early biochemical recurrence with superior detection rate and reader agreement when compared to F-18-Fluciclovine PET/CT in a prospective head-to-head comparative phase 3 study

Jeremie Calais, Francesco Ceci, Matthias Eiber, Jeannine Gartmann, Kathleen Nguyen, Vincent Lok, David Elashoff, Tristan Grogan, Roger Slavik, Robert Reiter, Matthew Rettig, Hossein Jadvar, Tore Bach-Gansmo, Bital Savir-Baruch, Michael Hofman, Cristina Nanni, Christoph Rischpler, Thomas Hope, Wolfgang Fendler, Johannes Czernin

Conference Proceedings  |  2019  |  JOURNAL OF NUCLEAR MEDICINE

PSMA-PET localizes M1 Disease in more than half of "non-metastatic" Castration-Resistant Prostate Cancer Patients

Wolfgang Fendler, Manuel Weber, Amir Iravani, Michael Hofman, Jeremie Calais, Johannes Czernin, Harun Ilhan, Tobias Maurer, Ken Herrmann, Thomas Hope, Isabel Rauscher, Boris Hadaschik, Matthias Eiber

Conference Proceedings  |  2019  |  JOURNAL OF NUCLEAR MEDICINE

Response assessment and immune-related adverse events as detected by FDG PET/CT in patients treated with combined CTLA-4 and PD-1 checkpoint inhibitors as first line therapy in advanced melanoma

Amir Iravani, Medhat Osman, Michael Hofman, Alison Weppler, George Au-Yeung, Shahneen Sandhu, Rodney Hicks

Conference Proceedings  |  2019  |  JOURNAL OF NUCLEAR MEDICINE

Automated radiosynthesis of [Lu-177] Lu-PSMA-617 on the iPHASE MultiSyn module

Christian Wichmann, Uwe Ackermann, Stan Poniger, Kenneth Young, James Chan, Michael Hofman, John Sachinidis, Andrew Scott

Conference Proceedings  |  2019  |  JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS

Dosimetry of Lu-177-PSMA-617 in Metastatic Castration-Resistant Prostate Cancer: Correlations Between Pretherapeutic Imaging and Whole-Body Tumor Dosimetry with Treatment Outcomes

John Violet, Price Jackson, Justin Ferdinandus, Shahneen Sandhu, Tim Akhurst, Amir Iravani, Grace Kong, Aravind Ravi Kumar, Sue Ping Thang, Peter Eu, Mark Scalzo, Declan Murphy, Scott Williams, Rodney J Hicks, Michael S Hofman

Journal article  |  2019  |  Journal of Nuclear Medicine

PATTERNS AND PREVALENCE OF IMMUNE-RELATED ADVERSE EVENTS AS DETECTED WITH FDG PET/CT IN PATIENTS TREATED WITH COMBINED CTLA-4 AND PD-1 INHIBITOR AS FIRST-LINE THERAPY FOR ADVANCED MELANOMA

A Iravani, MM Osman, MS Hofman, A Weppler, G Au-Yeung, S Sandhu, RJ Hicks

Conference Proceedings  |  2019  |  INTERNAL MEDICINE JOURNAL

AUTOMATED RADIOSYNTHESIS OF [177LU]LU-PSMA-617 ON THE IPHASE MULTISYN MODULE

C Wichmann, U Ackermann, Stan Poniger, K Young, G Chan, M Hofman, ST Lee, J Sachinidis, A Scott

Conference Proceedings  |  2019  |  INTERNAL MEDICINE JOURNAL

PROSTATE-SPECIFIC MEMBRANE ANTIGEN POSITRON EMISSION TOMOGRAPHY (PSMA-PET) IN HIGH-RISK NONMETASTATIC CASTRATION-RESISTANT PROSTATE CANCER (NMCRPC) SPARTAN-LIKE PATIENTS (PTS) NEGATIVE BY CONVENTIONAL IMAGING

Boris Hadaschik, Manuel Weber, Amir Iravani, Michael S Hofman, Jeremie Calais, Johannes Czernin, Harun Ilhan, Fred Saad, Eric J Small, Matthew R Smith, Paola M Perez, Thomas A Hope, Isabel Rauscher, Anil Londhe, Angela Lopez-Gitlitz, Shinta Cheng, Tobias Maurer, Ken Herrmann, Matthias Eiber, Wolfgang Fendler

Conference Proceedings  |  2019  |  JOURNAL OF UROLOGY

Strategies for Evaluation of Novel Imaging in Prostate Cancer: Putting the Horse Back Before the Cart

Neha Vapiwala, Michael S Hofman, Declan G Murphy, Scott Williams, Christopher Sweeney

Journal article  |  2019  |  Journal of Clinical Oncology

WELL-DIFFERENTIATED NEUROENDOCRINE NEOPLASM (NEN) WITH NO OR LOW (68)GA-DOTATATE AND F-18-FDG-AVIDITY: AN UNDER-RECOGNISED MOLECULAR IMAGING PHENOTYPE AND POTENTIAL MIMICKING PITFALLS

L Zidan, T Hung, G Kong, T Akhurst, A Ravikumar, M Hofman, R Hicks, A Iravani

Conference Proceedings  |  2019  |  INTERNAL MEDICINE JOURNAL

PSMA-PET results in a nonmetastatic castration-resistant prostate cancer spartan-like population that is negative by conventional imaging

M Hofman, W Fendler, M Weber, A Iravani, J Calais, J Czernin, H Ilhan, E Small, M Smith, T Maurer, K Herrmann, P Perez, T Hope, I Rauscher, A Londhe, A Lopez-Gitlitz, S Cheng, M Eiber, B Hadaschik

Conference Proceedings  |  2019  |  BJU INTERNATIONAL

Where to Next for Theranostics in Prostate Cancer?

Declan G Murphy, Niranjan Sathianathen, Michael S Hofman, Arun Azad, Nathan Lawrentschuk

Journal article  |  2019  |  European Urology Oncology

TheraP: A randomized phase II trial of [Lu-177]-PSMA-617 theranostic versus cabazitaxel in progressive metastatic castration-resistant prostate cancer

Michael Hofman, Louise Emmett, John A Violet, Nicola Jane Lawrence, Scott Williams, Martin R Stockler, Roslyn J Francis, Amir Iravani, Alison Yan Zhang, Andrew James Martin, Arun Azad, Sonia Yip, Ailsa Langford, Margaret Mary McJannett, Ian D Davis

Conference Proceedings  |  2019  |  Journal of Clinical Oncology

Highly favourable outcomes with peptide receptor radionuclide therapy (PRRT) for metastatic rectal neuroendocrine neoplasia (NEN)

Grace Kong, Simona Grozinsky-Glasberg, Michael S Hofman, Tim Akhurst, Amichay Meirovitz, Ofra Maimon, Yodphat Krausz, Jeremy Godefroy, Michael Michael, David J Gross, Rodney J Hicks

Journal article  |  2019  |  European Journal of Nuclear Medicine and Molecular Imaging

Results of a 50 patient single-center phase II prospective trial of Lutetium-177 PSMA-617 theranostics in metastatic castrate-resistant prostate cancer.

Michael Hofman, John A Violet, Rodney J Hicks, Justin Ferdinandus, Sue Ping Thang, Amir Iravani, Grace Kong, Aravind Ravi Kumar, Timothy J Akhurst, Jennifer Mooi, Christina Guo, Ben Tran, Price Jackson, Mark Scalzo, Peter Eu, Scott Williams, Shahneen Kaur Sandhu

Conference Proceedings  |  2019  |  Journal of Clinical Oncology

The VAMPIRE challenge: A multi-institutional validation study of CT ventilation imaging

John Kipritidis, Bilal A Tahir, Guillaume Cazoulat, Michael S Hofman, Shankar Siva, Jason Callahan, Nicholas Hardcastle, Tokihiro Yamamoto, Gary E Christensen, Joseph M Reinhardt, Noriyuki Kadoya, Taylor J Patton, Sarah E Gerard, Isabella Duarte, Ben Archibald-Heeren, Mikel Byrne, Rick Sims, Scott Ramsay, Jeremy T Booth, Enid Eslick, et al.

Journal article  |  2019  |  Medical Physics

The "ProPSMA Study" clinical trial protocol: A prospective randomized multi-center study of the impact of Ga-68 PSMA PET/CT imaging for staging high-risk prostate cancer prior to curative-intent surgery or radiotherapy.

Michael Hofman, Declan G Murphy, Scott Williams, Tatenda Nzenza, Alan Herschtal, Anetta Matera, Petra Marusic, Richard De Abreu Lourenco, Dale L Bailey, Amir Iravani, Rodney J Hicks, Roslyn J Francis, Nathan Lawrentschuk

Conference Proceedings  |  2019  |  Journal of Clinical Oncology

The Role of FDG - PET in Retroperitoneal Sarcomas - A Multicenter Retrospective Study

S Subramaniam, J Callahan, M Bressel, M Hofman, C Mitchell, S Hendry, FL Vissers, B van der Hiel, D Patel, WJ van Houdt, W Tseng, DE Gyorki

Conference Proceedings  |  2019  |  ANNALS OF SURGICAL ONCOLOGY

Characteristics and Outcomes of Therapy-Related Myeloid Neoplasms after Peptide Receptor Radionuclide Therapy (PRRT) for Metastatic Neuroendocrine Neoplasm (NEN): A Single Centre Series

I Goncalves, K Burbury, D Westerman, P Blombery, IS Tiong, A Iravani, A Ravikumar, M Michael, M Hofman, T Akhurst, R Hicks, G Kong

Conference Proceedings  |  2019  |  NEUROENDOCRINOLOGY

PET/CT Lung Ventilation and Perfusion Scanning using Galligas and Gallium-68-MAA

Pierre-Yves Le Roux, Rodney J Hicks, Shankar Siva, Michael S Hofman

Journal article  |  2019  |  Seminars in Nuclear Medicine

Valvular Replacement in Patients with Carcinoid Heart Disease (CaHD) - Preliminary Surgical Experience

G Kong, M Yong, P Ludhani, M Michael, J Morgan, M Hofman, R Hicks, M Larobina

Conference Proceedings  |  2019  |  NEUROENDOCRINOLOGY

A First-in-Human Study of Ga-68-Nanocolloid PET/CT Sentinel Lymph Node Imaging in Prostate Cancer Demonstrates Aberrant Lymphatic Drainage Pathways

Jacki A Doughton, Michael S Hofman, Peter Eu, Rodney J Hicks, Scott Williams

Journal article  |  2018  |  Journal of Nuclear Medicine

A pilot study of cardiopulmonary exercise testing and cardiac stress positron emission tomography before major non-cardiac surgery

MT Ferguson, MS Hofman, H Ismail, A Melville, KSK Yap, RJ Hicks, S Wright, B Riedel

Journal article  |  2018  |  Anaesthesia

A prospective randomized multicentre study of the impact of gallium-68 prostate-specific membrane antigen (PSMA) PET/CT imaging for staging high-risk prostate cancer prior to curative-intent surgery or radiotherapy (proPSMA study): clinical trial protocol

Michael S Hofman, Declan G Murphy, Scott G Williams, Tatenda Nzenza, Alan Herschtal, Richard De Abreu Lourenco, Dale L Bailey, Ray Budd, Rodney J Hicks, Roslyn J Francis, Nathan Lawrentschuk

Journal article  |  2018  |  BJU International

Using PSMA PET/CT to assess response in metastatic prostate cancer (mPC) patients (pts) receiving upfront chemohormonal therapy

A Anton, Z Ballok, P Bowden, T Costello, L Harewood, N Corcoran, P Dundee, J Peters, N Lawrentschuk, A Troy, D Webb, Y Chan, A See, S Siva, D Murphy, MS Hofman, B Tran

Conference Proceedings  |  2018  |  Annals of Oncology

Functional lung imaging in radiation therapy for lung cancer: A systematic review and meta-analysis

Nicholas W Bucknell, Nicholas Hardcastle, Mathias Bressel, Michael S Hofman, Tomas Kron, David Ball, Shankar Siva

Journal article  |  2018  |  Radiotherapy and Oncology

TROG 15.03 phase II clinical trial of Focal Ablative STereotactic Radiosurgery for Cancers of the Kidney - FASTRACK II

Shankar Siva, Brent Chesson, Mathias Bressel, David Pryor, Braden Higgs, Hayley M Reynolds, Nicholas Hardcastle, Rebecca Montgomery, Ben Vanneste, Vincent Khoo, Jeremy Ruben, Eddie Lau, Michael S Hofman, Richard De Abreu Lourenco, Swetha Sridharan, Nicholas R Brook, Jarad Martin, Nathan Lawrentschuk, Tomas Kron, Farshad Foroudi

Journal article  |  2018  |  BMC Cancer

Functional Lung Imaging in Radiotherapy for Lung Cancer: A Systematic Review and Meta-Analysis

N Bucknell, N Hardcastle, M Bressel, M Hofman, T Kron, S Siva

Conference Proceedings  |  2018  |  Journal of Thoracic Oncology

Stereotactic Abative Body Radiotherapy (SABR) for Oligometastatic Prostate Cancer: A Prospective Clinical Trial

Shankar Siva, Mathias Bressel, Declan G Murphy, Mark Shaw, Sarat Chander, John Violet, Keen Hun Tai, Cristian Udovicich, Andrew Lim, Lisa Selbie, Michael S Hofman, Tomas Kron, Daniel Moon, Jeremy Goad, Nathan Lawrentschuk, Farshad Foroudi

Journal article  |  2018  |  European Urology

Guidelines on nuclear medicine imaging in neuroblastoma

Zvi Bar-Sever, Lorenzo Biassoni, Barry Shulkin, Grace Kong, Michael S Hofman, Egesta Lopci, Irina Manea, Jacek Koziorowski, Rita Castellani, Ariane Boubaker, Bieke Lambert, Thomas Pfluger, Helen Nadel, Susan Sharp, Francesco Giammarile

Journal article  |  2018  |  European Journal of Nuclear Medicine and Molecular Imaging

Induction PRRT With CAPTEM Chemotherapy in a High-risk Population of Metastatic Neuroendocrine Neoplasia (NEN): Balancing Efficacy With Risk

AS Ravi Kumar, J Ferdinandus, J Callahan, T Akhurst, MS Hofman, A Iravani, G Kong, M Michael, RJ Hicks

Conference Proceedings  |  2018  |  EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Voxel based dosimetry of Lu-177-PSMA-617 within a prospective clinical trial: Whole body tumour dosimetry and correlations with pre-therapeutic imaging and biochemical outcomes

JA Violet, P Jackson, J Ferdinandus, S Thang, S Sandhu, M Scalzo, RJ Hicks, MS Hofman

Conference Proceedings  |  2018  |  EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

[Lu-177]-PSMA-617 radionuclide therapy in patients with metastatic castration-resistant prostate cancer reply

Michael S Hofman, John Violet, Rodney J Hicks, Shahneen Sandhu

Journal article  |  2018  |  The Lancet Oncology

Advances in Urologic Imaging Prostate-Specific Membrane Antigen Ligand PET Imaging

Michael S Hofman, Amir Iravani, Tatenda Nzenza, Declan G Murphy

Journal article  |  2018  |  Urologic Clinics of North America

Incidental Metastatic Melanoma Identified on 68Ga-Prostate-Specific Membrane Antigen PET/CT for Metastatic Prostate Cancer

Hayden A Snow, Michael S Hofman, Catherine A Mitchell, David E Gyorki, Myles JF Smith

Journal article  |  2018  |  Clinical Nuclear Medicine

Deep Learning Renal Segmentation for Fully Automated Radiation Dose Estimation in Unsealed Source Therapy

Price Jackson, Nicholas Hardcastle, Noel Dawe, Tomas Kron, Michael S Hofman, Rodney J Hicks

Journal article  |  2018  |  Frontiers in Oncology

[Lu-177]-PSMA-617 radionuclide treatment in patients with metastatic castration-resistant prostate cancer (LuPSMA trial): a single-centre, single-arm, phase 2 study

Michael S Hofman, John Violet, Rodney J Hicks, Justin Ferdinandus, Sue Ping Thang, Tim Akhurst, Amir Iravani, Grace Kong, Aravind Ravi Kumar, Declan G Murphy, Peter Eu, Price Jackson, Mark Scalzo, Scott G Williams, Shahneen Sandhu

Journal article  |  2018  |  The Lancet Oncology

Lutetium-177 PSMA617 theranostics in metastatic castrate-resistant prostate cancer (mCRPC): Interim results of a phase II trial.

Shahneen Kaur Sandhu, John A Violet, Justin Ferdinandus, Sue-Ping Thang, Amir Iravani, Christina Guo, Grace Kong, Aravind Ravi Kumar, Timothy J Akhurst, Alexis Beaulieu, Declan G Murphy, Jennifer Mooi, Ben Tran, Guy C Toner, Scott Williams, Rodney J Hicks, Michael Hofman

Conference Proceedings  |  2018  |  Journal of Clinical Oncology

The poor outcome of patients with mCRPC whom were deemed ineligible for PSMA theranostics based on molecular imaging characteristics.

Sue Ping Thang, John A Violet, Shahneen Kaur Sandhu, Amir Iravani, Timothy J Akhurst, Aravind Ravi Kumar, Grace Kong, Scott Williams, Rodney J Hicks, Michael Hofman, Michael Hofman

Conference Proceedings  |  2018  |  Journal of Clinical Oncology

F-18-FDG-Avid Thyroid Incidentalomas: The Importance of Contextual Interpretation

David A Pattison, Michael Bozin, Alexandra Gorelik, Michael S Hofman, Rodney J Hicks, Anita Skandarajah

Journal article  |  2018  |  Journal of Nuclear Medicine

Prognostic value of baseline imaging parameters prior to therapy with Lu-177-PSMA-617

Justin Ferdinandus, Sue Ping Thang, John Violet, Rodney Hicks, Shahneen Sandhu, Michael Hofman

Conference Proceedings  |  2018  |  JOURNAL OF NUCLEAR MEDICINE

Patterns of Physiologic F-18-DCFPyL PSMA PET/CT Uptake in Ganglia: A Pictorial Essay

Medhat Osman, Amir Iravani, Rodney Hicks, Michael Hofman

Conference Proceedings  |  2018  |  JOURNAL OF NUCLEAR MEDICINE

Association of primary, nodal and total metabolic tumor volume with response assessment and overall survival in non-surgical non-small-cell lung cancer (NSCLC) patients treated by radical chemo-radiotherapy

Amir Iravani, Guy-Anne Turgeon, T Akhurst, Mathias Bressel, Sarah Everitt, Shankar Siva, Michael Hofman, Rodney Hicks, David Ball, Michael MacManus

Conference Proceedings  |  2018  |  JOURNAL OF NUCLEAR MEDICINE

High activity, pain reduction and low toxicity with Lutetium-177 PSMA617 theranostics in metastatic castrate-resistant prostate cancer (mCRPC): results of a phase II prospective trial

Michael Hofman, John Violet, Shahneen Sandhu, Justin Ferdinandus, Sue Ping Thang, Amir Iravani, Grace Kong, Aravind Ravi Kumar, Tim Akhurst, Price Jackson, Mark Scalzo, Scott Williams, Rodney Hicks

Conference Proceedings  |  2018  |  JOURNAL OF NUCLEAR MEDICINE

Inflammatory non-tumor FDG uptake in the lung on early follow-up PET/CT in non-small-cell lung cancer patients treated by chemo-radiotherapy: association with response and overall survival

Amir Iravani, Guy-Anne Turgeon, T Akhurst, Mathias Bressel, Sarah Everitt, Shankar Siva, Michael Hofman, Rodney Hicks, David Ball, Michael MacManus

Conference Proceedings  |  2018  |  JOURNAL OF NUCLEAR MEDICINE

THE ROLE OF (68)GA-DOTA-OCTREOTATE (GATATE) PET/CT IN FOLLOW-UP OF PATIENTS WITH SDH-ASSOCIATED PHEOCHROMOCYTOMA AND PARAGANGLIOMA (PPGL)

G Kong, T Schenberg, A Iravani, M Hofman, A Ravikumar, T Akhurst, R Hicks

Conference Proceedings  |  2018  |  INTERNAL MEDICINE JOURNAL

Cold Kit for Prostate-Specific Membrane Antigen (PSMA) PET Imaging: Phase 1 Study of Ga-68-Tris (Hydroxypyridinone)-PSMA PET/CT in Patients with Prostate Cancer

Michael S Hofman, Peter Eu, Price Jackson, Emily Hong, David Binns, Amir Iravani, Declan Murphy, Catherine Mitchell, Shankar Siva, Rodney J Hicks, Jennifer D Young, Philip J Blower, Gregory E Mullen

Journal article  |  2018  |  Journal of Nuclear Medicine

SELECTIVE MITOGEN ACTIVATED PROTEIN KINASE (MAPK) PATHWAY INHIBITION IN RADIOIODINE REFRACTORY DIFFERENTIATED THYROID CANCER: A SINGLE CENTER EXPERIENCE

A Iravani, G Kong, ML Hofman, AR Kumar, T Akhurst, B Solomon, R Hicks

Conference Proceedings  |  2018  |  INTERNAL MEDICINE JOURNAL

Accuracy of Dose Calibrators for Ga-68 PET Imaging: Unexpected Findings in a Multicenter Clinical Pretrial Assessment

Dale L Bailey, Michael S Hofman, Nicholas J Forwood, Graeme J O'Keefe, Andrew M Scott, Winifred M van Wyngaardt, Bonnie Howe, Olga Kovacev, Roslyn J Francis

Journal article  |  2018  |  Journal of Nuclear Medicine

Prostate-specific membrane antigen theranostics: therapy with lutetium-177

Justin Ferdinandus, John Violet, Shahneen Sandhu, Michael S Hofman

Journal article  |  2018  |  Current Opinion in Urology

Oligometastatic Renal Cell Carcinoma With Sarcomatoid Differentiation Demonstrating Variable Imaging Phenotypes on Ga-68-PSMA and F-18-FDG PET/CT: A Case Report and Review of the Literature

David P Nadebaum, Michael S Hofman, Catherine A Mitchell, Shankar Siva, Rodney J Hicks

Journal article  |  2018  |  Clinical Genitourinary Cancer

Peptide receptor radionuclide therapy (PRRT) in European Neuroendocrine Tumour Society (ENETS) grade 3 (G3) neuroendocrine neoplasia (NEN) - a single-institution retrospective analysis

Sue Ping Thang, Mei Sim Lung, Grace Kong, Michael S Hofman, Jason Callahan, Michael Michael, Rodney J Hicks

Journal article  |  2018  |  European Journal of Nuclear Medicine and Molecular Imaging

AGITG nabnec: A randomised phase II study of nab-paclitaxel in combination with carboplatin as first line treatment of gastrointestinal neuroendocrine carcinomas.

Lorraine A Chantrill, Lara Rachel Lipton, Michael Hofman, Val Gebski, Anthony Gill, Ben Markman, Sonia Yip, Christos Stelios Karapetis, Nick Pavlakis, Shu Fen Wong, David Turner Ransom, Katrin Marie Sjoquist, Adnan Nagrial, Michael Michael, Uzma Rayani, Martinus Oostendorp, John Simes, Mustafa Khasraw

Conference Proceedings  |  2018  |  Journal of Clinical Oncology

Use of PSMA PET/CT in biochemical recurrence post radical prostatectomy: Our local experience

T Nzenza, W Ranasinghe, D Murphy, M Hofman, D Bolton, N Lawrentschuk

Conference Proceedings  |  2018  |  BJU INTERNATIONAL

Changes in biodistribution on Ga-68-DOTA-Octreotate PET/CT after long acting somatostatin analogue therapy in neuroendocrine tumour patients may result in pseudoprogression

Martin H Cherk, Grace Kong, Rodney J Hicks, Michael S Hofman

Journal article  |  2018  |  Cancer Imaging

Favourable Outcomes of Peptide Receptor Radionuclide Therapy (PRRT) for Treatment of Metastatic Rectal Neuroendocrine Neoplasia (NEN)

G Kong, S Grozinsky-Glasberg, T Akhurst, M Hofman, A Meirovitz, O Maimon, A Schwartz, M Michael, DJ Gross, R Hicks

Conference Proceedings  |  2018  |  NEUROENDOCRINOLOGY

Prostate-specific Membrane Antigen PET: Clinical Utility in Prostate Cancer, Normal Patterns, Pearls, and Pitfalls

Michael S Hofman, Rodney J Hicks, Tobias Maurer, Matthias Eiber

Journal article  |  2018  |  RadioGraphics

Ga-68 PSMA-11 PET with CT urography protocol in the initial staging and biochemical relapse of prostate cancer

Amir Iravani, Michael S Hofman, Tony Mulcahy, Scott Williams, Declan Murphy, Bimal K Parameswaran, Rodney J Hicks

Journal article  |  2017  |  Cancer Imaging

Detection of Synchronous Primary Malignancies with Ga-68-Labeled Prostate-Specific Membrane Antigen PET/CT in Patients with Prostate Cancer: Frequency in 764 Patients

Medhat M Osman, Amir Iravani, Rodney J Hicks, Michael S Hofman

Journal article  |  2017  |  Journal of Nuclear Medicine

Ga-68-prostate-specific membrane antigen-positron emission tomography/computed tomography in advanced prostate cancer: Current state and future trends

Cristian Udovicich, Marlon Perera, Michael S Hofman, Shankar Siva, Andres Del Rio, Declan G Murphy, Nathan Lawrentschuk

Journal article  |  2017  |  Prostate International

Automatic delineation of functional lung volumes with Ga-68-ventilation/perfusion PET/CT

Pierre-Yves Le Roux, Shankar Siva, Jason Callahan, Yannis Claudic, David Bourhis, Daniel P Steinfort, Rodney J Hicks, Michael S Hofman

Journal article  |  2017  |  EJNMMI Research

Accuracy in the Eye of the Beholder: Can We Improve Agreement in Prostate Cancer Diagnostics with PSMA PET/CT?

Michael S Hofman

Journal article  |  2017  |  Journal of Nuclear Medicine

Peptide receptor radionuclide therapy (PRRT) in ENETS Grade 3 (G3) Neuroendocrine Neoplasia (NEN) - a single-institution retrospective analysis

S Thang, M Lung, G Kong, M Hofman, J Callahan, M Michael, R Hicks

Conference Proceedings  |  2017  |  EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Prostate-Specific Membrane Antigen Ligands for Imaging and Therapy

Matthias Eiber, Wolfgang P Fendler, Steven P Rowe, Jeremie Calais, Michael S Hofman, Tobias Maurer, Sarah M Schwarzenboeck, Clemens Kratowchil, Ken Herrmann, Frederik L Giesel

Journal article  |  2017  |  Journal of Nuclear Medicine

Development of standardized image interpretation for 68Ga-PSMA PET/CT to detect prostate cancer recurrent lesions

Stefano Fanti, Silvia Minozzi, Joshua James Morigi, Frederik Giesel, Francesco Ceci, Christian Uprimny, Michael S Hofman, Matthias Eiber, Sarah Schwarzenbock, Paolo Castellucci, Cristina Bellisario, Stephane Chauvie, Fabrizio Bergesio, Louise Emmett, Uwe Haberkorn, Irene Virgolini, Markus Schwaiger, Rodney J Hicks, Bernd J Krause, Arturo Chiti

Journal article  |  2017  |  European Journal of Nuclear Medicine and Molecular Imaging

Reduced ventilation-perfusion (V/Q) mismatch following endobronchial valve insertion demonstrated by Gallium-68 V/Q photon emission tomography/computed tomography

Paul Leong, Pierre-Yves Le Roux, Jason Callahan, Shankar Siva, Michael S Hofman, Daniel P Steinfort

Journal article  |  2017  |  Respirology Case Reports

Prostate-specific membrane antigen from diagnostic to therapeutic target: radionuclide therapy comes of age in prostate cancer

John A Violet, Michael S Hofman

Journal article  |  2017  |  BJU International

Efficacy of Peptide Receptor Radionuclide Therapy for Functional Metastatic Paraganglioma and Pheochromocytoma

Grace Kong, Simona Grozinsky-Glasberg, Michael S Hofman, Jason Callahan, Amichay Meirovitz, Ofra Maimon, David A Pattison, David J Gross, Rodney J Hicks

Journal article  |  2017  |  The Journal of Clinical Endocrinology & Metabolism

The Advantages and Challenges of Using FDG PET/CT for Response Assessment in Melanoma in the Era of Targeted Agents and Immunotherapy

Annie NM Wong, Grant A McArthur, Michael S Hofman, Rodney J Hicks

Journal article  |  2017  |  European Journal of Nuclear Medicine and Molecular Imaging

Utility of Ga-68 prostate specific membrane antigen - positron emission tomography in diagnosis and response assessment of recurrent renal cell carcinoma

Shankar Siva, Jason Callahan, David Pryor, Jarad Martin, Nathan Lawrentschuk, Michael S Hofman

Journal article  |  2017  |  Journal of Medical Imaging and Radiation Oncology

EORTC PET response criteria are more influenced by reconstruction inconsistencies than PERCIST but both benefit from the EARL harmonization program

Charline Lasnon, Elske Quak, Pierre-Yves Le Roux, Philippe Robin, Michael S Hofman, David Bourhis, Jason Callahan, David S Binns, Cedric Desmonts, Pierre-Yves Salaun, Rodney J Hicks, Nicolas Aide

Journal article  |  2017  |  EJNMMI Physics

Outcomes of peptide receptor radionuclide therapy (PRRT) in metastatic grade 3 neuroendocrine tumors (NETs).

Mei Sim Lung, Michael Hofman, Grace Kong, Sue-Ping Thang, Michael Michael, Rodney J Hicks

Conference Proceedings  |  2017  |  Journal of Clinical Oncology

Lu-177-Dotatate for Midgut Neuroendocrine Tumors

Michael S Hofman, Michael Michael, Rodney J Hicks

Journal article  |  2017  |  New England Journal of Medicine

Gallium-68 Prostate-Specific Membrane Antigen PET Imaging

Michael S Hofman, Amir Iravani

Journal article  |  2017  |  PET Clinics

High clinical and morphologic response using Y-90-DOTA-octreotate sequenced with Lu-177-DOTA-octreotate induction peptide receptor chemoradionuclide therapy (PRCRT) for bulky neuroendocrine tumours

Grace Kong, Jason Callahan, Michael S Hofman, David A Pattison, Tim Akhurst, Michael Michael, Peter Eu, Rodney J Hicks

Journal article  |  2017  |  EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Early Treatment Intensification With R-ICE And 90Y-Ibritumomab Tiuxetan (Zevalin)-BEAM Stem Cell Transplantation In Patients With High Risk Diffuse Large B-Cell Lymphoma Patients And Positive Interim PET After 4 Cycles Of R-CHOP-14

Mark Hertzberg, Maher K Gandhi, Judith Trotman, Belinda Butcher, John Taper, Amanda Johnston, Devinder Gill, Shir-Jing Ho, Gavin Cull, Keith Fay, Geoff Chong, Andrew Grigg, Ian D Lewis, Sam Milliken, William Renwick, Uwe Hahn, Robin Filshie, George Kannourakis, Anne-Marie Watson, Pauline Warburton, et al.

Journal article  |  2017  |  Haematologica

Bringing clarity or confusion? The role of prostate-specific membrane antigen positron-emission/computed tomography for primary staging in prostate cancer

Declan G Murphy, Michael Hofman, Nathan Lawrentschuk, Tobias Maurer

Journal article  |  2017  |  BJU International

Reply to Fabio Zattoni, Filiberto Zattoni, and Laura Evangelista's Letter to the Editor re: Marlon Perera, Nathan Papa, Daniel Christidis, et al. Sensitivity, Specificity, and Predictors of Positive Ga-68-Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer: A Systematic Review and Meta-analysis. Eur Urol 2016;70:926-37

Nathan Papa, Marlon Perera, Michael S Hofman, Damien Bolton, Nathan Lawrentschuk

Journal article  |  2017  |  European Urology

Glut-1 expression in small cervical biopsies is prognostic in cervical cancers treated with chemoradiation

Yada Kanjanapan, Siddhartha Deb, Richard J Young, Mathias Bressel, Linda Mileshkin, Danny Rischin, Michael S Hofman, Kailash Narayan, Shankar Siva

Journal article  |  2017  |  Clinical and Translational Radiation Oncology

PSMA-PET for Lymph Node Detection in Recurrent Prostate Cancer: How do we use the Magic Bullet?

Tobias Maurer, Declan G Murphy, Michael S Hofman, Matthias Eiber

Journal article  |  2017  |  Theranostics

FDG PET in follicular lymphoma: more than a staging test?

Aravind S Ravi Kumar, Constantine Tam, Michael S Hofman

Journal article  |  2017  |  Leukemia & Lymphoma

Principles and Application of Molecular Imaging for Personalized Medicine and Guiding Interventions in Neuroendocrine Tumors

MS Hofman

Book Chapter  |  2017

Early warning signs: FDG-PET to diagnose bleomycin toxicity

Michael Dickinson, Lou Irving, Michael Hofman

Journal article  |  2017  |  Leukemia & Lymphoma

'Hot spot' cardiac ischemia imaging with fluorodeoxyglucose positron emission tomography

Marissa T Ferguson, Andrew Mallia, Kenneth Yap, Samuel Wright, Rodney J Hicks, Michael S Hofman

Journal article  |  2016  |  Journal of Nuclear Cardiology

Sensitivity, Specificity, and Predictors of Positive Ga-68-Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer: A Systematic Review and Meta-analysis

Marlon Perera, Nathan Papa, Daniel Christidis, David Wetherell, Michael S Hofman, Declan G Murphy, Damien Bolton, Nathan Lawrentschuk

Journal article  |  2016  |  European Urology

Neuraxial Anesthesia Reduces Lymphatic Flow: Proof-of-Concept in First In-Human Study

Jonathan G Hiller, Hilmy M Ismail, Michael S Hofman, Kailash Narayan, Shakher Ramdave, Bernhard J Riedel

Journal article  |  2016  |  Anesthesia & Analgesia

Intense focal pituitary FDG uptake due to intravascular large B-cell lymphoma in pyrexia of unknown origin

David A Pattison, Michael S Hofman, Ali Bazargan, Peter Colman, Rodney J Hicks

Journal article  |  2016  |  American Journal of Hematology

Does PET SUV Harmonization Affect PERCIST Response Classification?

Elske Quak, Pierre-Yves Le Roux, Charline Lasnon, Philippe Robin, Michael S Hofman, David Bourhis, Jason Callahan, David S Binns, Cedric Desmonts, Pierre-Yves Salaun, Rodney J Hicks, Nicolas Aide

Journal article  |  2016  |  Journal of Nuclear Medicine

How We Read Oncologic FDG PET/CT

Michael S Hofman, Rodney J Hicks

Journal article  |  2016  |  Cancer Imaging

Gallium-68 EDTA PET/CT for Renal Imaging

Michael S Hofman, Rodney J Hicks

Journal article  |  2016  |  Seminars in Nuclear Medicine

Rapidly changing landscape of PET/CT imaging in prostate cancer

Joshua J Morigi, S Fanti, D Murphy, Michael S Hofman

Journal article  |  2016  |  Current Opinion in Urology

Gallium-68 perfusion positron emission tomography/computed tomography to assess pulmonary function in lung cancer patients undergoing surgery

Pierre-Yves Le Roux, Tracy L Leong, Stephen A Barnett, Rodney J Hicks, Jason Callahan, Peter Eu, Renee Manser, Michael S Hofman

Journal article  |  2016  |  Cancer Imaging

Ga-68-DOTATATE and F-18-FDG PET/CT in Paraganglioma and Pheochromocytoma: utility, patterns and heterogeneity

Chian A Chang, David A Pattison, Richard W Tothill, Grace Kong, Tim J Akhurst, Rodney J Hicks, Michael S Hofman

Journal article  |  2016  |  Cancer Imaging

Initial Experience With Gallium-68 DOTA-Octreotate PET/CT and Peptide Receptor Radionuclide Therapy for Pediatric Patients With Refractory Metastatic Neuroblastoma

Grace Kong, Michael S Hofman, William K Murray, Sharyn Wilson, Paul Wood, Peter Downie, Leanne Super, Annette Hogg, Peter Eu, Rodney J Hicks

Journal article  |  2016  |  Journal of Pediatric Hematology/Oncology

Short and long-term prognostic implications of a low embolic burden in oncology patients diagnosed with symptomatic pulmonary embolism

Pierre-Yves Le Roux, Kate Burbury, Michael S Hofman, Rodney J Hicks

Journal article  |  2016  |  Annals of Hematology

Impact of stereotactic radiotherapy on kidney function in primary renal cell carcinoma: Establishing a dose-response relationship

Shankar Siva, Price Jackson, Tomas Kron, Mathias Bressel, Eddie Lau, Michael Hofman, Mark Shaw, Sarat Chander, Daniel Pham, Nathan Lawrentschuk, Lih-Ming Wong, Jeremy Goad, Farshad Foroudi

Journal article  |  2016  |  Radiotherapy and Oncology

Ga-68 MAA Perfusion 4D-PET/CT Scanning Allows for Functional Lung Avoidance Using Conformal Radiation Therapy Planning

Shankar Siva, Thomas Devereux, David L Ball, Michael P MacManus, Nicholas Hardcastle, Tomas Kron, Mathias Bressel, Farshad Foroudi, Nikki Plumridge, Daniel Steinfort, Mark Shaw, Jason Callahan, Rodney J Hicks, Michael S Hofman

Journal article  |  2016  |  TECHNOLOGY IN CANCER RESEARCH & TREATMENT

Estimating lung ventilation directly from 4D CT Hounsfield unit values

John Kipritidis, Michael S Hofman, Shankar Siva, Jason Callahan, Pierre-Yves Le Roux, Henry C Woodruff, William B Counter, Paul J Keall

Journal article  |  2016  |  Medical Physics

Harmonizing FDG PET quantification while maintaining optimal lesion detection: prospective multicentre validation in 517 oncology patients

Elske Quak, Pierre-Yves Le Roux, Michael S Hofman, Philippe Robin, David Bourhis, Jason Callahan, David Binns, Cedric Desmonts, Pierre-Yves Salaun, Rodney J Hicks, Nicolas Aide

Journal article  |  2015  |  European Journal of Nuclear Medicine and Molecular Imaging

ADVANCES IN THE IMAGING OF THE PROSTATE IN THE SETTING OF ELEVATED PSA LEVELS

Rodney J Hicks, Bimal K Parameswaran, Michael S Hofman, Declan G Murphy, Nathan Lawrentschuk, Scott G Williams

Journal article  |  2015  |  Cancer Forum

Correlation of Ga-68 Ventilation-Perfusion PET/CT with Pulmonary Function Test Indices for Assessing Lung Function

Pierre-Yves Le Roux, Shankar Siva, Daniel P Steinfort, Jason Callahan, Peter Eu, Lou B Irving, Rodney J Hicks, Michael S Hofman

Journal article  |  2015  |  Journal of Nuclear Medicine

Ventilation/Perfusion Positron Emission Tomography-Based Assessment of Radiation Injury to Lung

Shankar Siva, Nicholas Hardcastle, Tomas Kron, Mathias Bressel, Jason Callahan, Michael P MacManus, Mark Shaw, Nikki Plumridge, Rodney J Hicks, Daniel Steinfort, David L Ball, Michael S Hofman

Journal article  |  2015  |  International Journal of Radiation Oncology*Biology*Physics

Role of Fluorodeoxyglucose PET/Computed Tomography in Targeted Radionuclide Therapy for Endocrine Malignancies

David A Pattison, Michael S Hofman

Journal article  |  2015  |  PET Clinics

Moving Beyond "Lumpology": PET/CT Imaging of Pheochromocytoma and Paraganglioma

Michael S Hofman, Rodney J Hicks

Journal article  |  2015  |  Clinical Cancer Research

Accuracy and Utility of Deformable Image Registration in Ga-68 4D PET/CT Assessment of Pulmonary Perfusion Changes During and After Lung Radiation Therapy

Nicholas Hardcastle, Michael S Hofman, Rodney J Hicks, Jason Callahan, Tomas Kron, Michael P MacManus, David L Ball, Price Jackson, Shankar Siva

Journal article  |  2015  |  International Journal of Radiation Oncology*Biology*Physics

Distribution Atlas of Proliferating Bone Marrow in Non-Small Cell Lung Cancer Patients Measured by FLT-PET/CT Imaging, With Potential Applicability in Radiation Therapy Planning

Belinda A Campbell, Jason Callahan, Mathias Bressel, Nathalie Simoens, Sarah Everitt, Michael S Hofman, Rodney J Hicks, Kate Burbury, Michael MacManus

Journal article  |  2015  |  International Journal of Radiation Oncology*Biology*Physics

Pulmonary Scintigraphy for the Diagnosis of Acute Pulmonary Embolism: A Survey of Current Practices in Australia, Canada, and France

Pierre-Yves Le Roux, Matthieu Pelletier-Galarneau, Romain De Laroche, Michael S Hofman, Lionel S Zuckier, Paul Roach, Jean-Philippe Vuillez, Rodney J Hicks, Gregoire Le Gal, Pierre-Yves Salaun

Journal article  |  2015  |  Journal of Nuclear Medicine

Current status of FDG-PET/CT in staging of adult lymphoma

Alberto Biggi, Luca Guerra, Michael S Hofman

Journal article  |  2015  |  Clinical and Translational Imaging

Modifying the Poor Prognosis Associated with F-18-FDG-Avid NET with Peptide Receptor Chemo-Radionuclide Therapy (PRCRT)

Michael S Hofman, Michael Michael, Raghava Kashyap, Rodney J Hicks

Journal article  |  2015  |  Journal of Nuclear Medicine

High-resolution pulmonary ventilation and perfusion PET/CT allows for functionally adapted intensity modulated radiotherapy in lung cancer

Shankar Siva, Roshini Thomas, Jason Callahan, Nicholas Hardcastle, Daniel Pham, Tomas Kron, Rodney J Hicks, Michael P MacManus, David L Ball, Michael S Hofman

Journal article  |  2015  |  Radiotherapy and Oncology

Somatostatin Receptor Imaging with Ga-68 DOTATATE PET/CT: Clinical Utility, Normal Patterns, Pearls, and Pitfalls in Interpretation

Michael S Hofman, WF Eddie Lau, Rodney J Hicks

Journal article  |  2015  |  RadioGraphics

Ga-68-EDTA PET/CT Imaging and Plasma Clearance for Glomerular Filtration Rate Quantification: Comparison to Conventional Cr-51-EDTA

Michael Hofman, David Binns, Val Johnston, Shankar Siva, Mick Thompson, Peter Eu, Marnie Collins, Rodney J Hicks

Journal article  |  2015  |  Journal of Nuclear Medicine

Re: Palliative bypass for small bowel carcinoid with mesenteric mass and vascular encasement

Benjamin NJ Thomson, Michael S Hofman, Rodney J Hicks

Journal article  |  2015  |  ANZ Journal of Surgery

Favourable outcomes of Lu-177-octreotate peptide receptor chemoradionuclide therapy in patients with FDG-avid neuroendocrine tumours

Raghava Kashyap, Michael S Hofman, Michael Michael, Grace Kong, Timothy Akhurst, Peter Eu, Diana Zannino, Rodney J Hicks

Journal article  |  2015  |  European Journal of Nuclear Medicine and Molecular Imaging

The utility and limitations of F-18-fluorodeoxyglucose positron emission tomography with computed tomography in patients with primary mediastinal B-cell lymphoma: single institution experience and literature review

Chan Y Cheah, Michael S Hofman, John F Seymour, David S Ritchie, Michael Dickinson, Andrew Wirth, H Miles Prince, Max Wolf, Elchanan H Januszcewicz, Dennis A Carney, Kirsten E Herbert, Simon J Harrison, Kate L Burbury, Constantine S Tam

Journal article  |  2015  |  Leukemia & Lymphoma

Prolonged life-threatening hypoglycaemia following dose escalation of octreotide LAR in a patient with malignant polysecreting pancreatic neuroendocrine tumour

Sally K Abell, Jessie Teng, Anthony Dowling, Michael S Hofman, Richard J MacIsaac, Nirupa Sachithanandan

Journal article  |  2015  |  Endocrinology, Diabetes & Metabolism Case Reports

Protracted hypocalcaemia following a single dose of denosumab in humoral hypercalcaemia of malignancy due to PTHrP-secreting neuroendocrine tumour

Jessie Teng, Sally Abell, Rodney J Hicks, Michael S Hofman, Nirupa Sachithanandan, Penny McKelvie, Richard J MacIsaac

Journal article  |  2014  |  Clinical Endocrinology

Short communication: timeline of radiation-induced kidney function loss after stereotactic ablative body radiotherapy of renal cell carcinoma as evaluated by serial Tc-99m-DMSA SPECT/CT

Price Jackson, Farshad Foroudi, Daniel Pham, Michael S Hofman, Nicholas Hardcastle, Jason Callahan, Tomas Kron, Shankar Siva

Journal article  |  2014  |  Radiation Oncology

A prospective observational study of Gallium-68 ventilation and perfusion PET/CT during and after radiotherapy in patients with non-small cell lung cancer

Shankar Siva, Jason Callahan, Tomas Kron, Olga A Martin, Michael P MacManus, David L Ball, Rodney J Hicks, Michael S Hofman

Journal article  |  2014  |  BMC Cancer

Assessment of predictors of response and long-term survival of patients with neuroendocrine tumour treated with peptide receptor chemoradionuclide therapy (PRCRT)

G Kong, M Thompson, M Collins, A Herschtal, MS Hofman, V Johnston, P Eu, M Michael, Rodney J Hicks

Journal article  |  2014  |  European Journal of Nuclear Medicine and Molecular Imaging

PET Screening for Metastatic Colorectal Adenocarcinoma

Ching-yee Oliver Wong, Prashant Jolepalem

Journal article  |  2014  |  JAMA

Enhanced White Adipose Tissue Metabolism in Iatrogenic Cushing's Syndrome With FDG PET/CT

David A Pattison, Michael S Hofman, Eddie Lau, Rob Ware, Rodney J Hicks

Journal article  |  2014  |  The Journal of Clinical Endocrinology & Metabolism

Limited clinical benefit for surveillance PET-CT scanning in patients with histologically transformed lymphoma in complete metabolic remission following primary therapy

Chan Y Cheah, Michael Dickinson, Michael S Hofman, Anupkumar George, David S Ritchie, H Miles Prince, David Westerman, Simon J Harrison, Kate Burbury, Max Wolf, Henry Januszewicz, Kirsten E Herbert, Dennis A Carney, Constantine Tam, John F Seymour

Journal article  |  2014  |  Annals of Hematology

The predictive role of interim positron emission tomography for Hodgkin lymphoma treatment outcome is confirmed using the interpretation criteria of the Deauville five-point scale

Andrea Gallamini, Sally F Barrington, Alberto Biggi, Stephane Chauvie, Lale Kostakoglu, Michele Gregianin, Michel Meignan, George N Mikhaeel, Annika Loft, Jan M Zaucha, John F Seymour, Michael S Hofman, Luigi Rigacci, Alessandro Pulsoni, Morton Coleman, Eldad J Dann, Livio Trentin, Olivier Casasnovas, Chiara Rusconi, Pauline Brice, et al.

Journal article  |  2014  |  Haematologica

Peptide receptor radionuclide therapy for neuroendocrine tumours: standardized and randomized, or personalized?

Michael S Hofman, Rodney J Hicks

Journal article  |  2014  |  European Journal of Nuclear Medicine and Molecular Imaging

High-resolution imaging of pulmonary ventilation and perfusion with Ga-68-VQ respiratory gated (4-D) PET/CT

Jason Callahan, Michael S Hofman, Shankar Siva, Tomas Kron, Michal E Schneider, David Binns, Peter Eu, Rodney J Hicks

Journal article  |  2014  |  European Journal of Nuclear Medicine and Molecular Imaging

Unintended consequences: might major surgery accelerate cancer?

Michael S Hofman

Journal article  |  2014  |  BMJ

POLYMYALGIA RHEUMATICA Fluorodeoxyglucose positron emission tomography/computed tomography: a "one stop shop" for diagnosing polymyalgia rheumatica

Michael S Hofman

Journal article  |  2014  |  BMJ

Segmental Hyperperfusion in Lobar Pneumonia Visualized with Respiratory-gated Four-Dimensional Pulmonary Perfusion Positron Emission Tomography-Computed Tomography

Michael S Hofman, Jason Callahan, Peter Eu, Rodney J Hicks

Journal article  |  2014  |  American Journal of Respiratory and Critical Care Medicine

Validating and improving CT ventilation imaging by correlating with ventilation 4D-PET/CT using Ga-68-labeled nanoparticles

John Kipritidis, Shankar Siva, Michael S Hofman, Jason Callahan, Rodney J Hicks, Paul J Keall

Journal article  |  2014  |  Medical Physics

Rapid blood clearance and lack of long-term renal toxicity of Lu-177-DOTATATE enables shortening of renoprotective amino acid infusion

Raghava Kashyap, Price Jackson, Michael S Hofman, Peter Eu, Jean-Mathieu Beauregard, Diana Zannino, Rodney J Hicks

Journal article  |  2013  |  European Journal of Nuclear Medicine and Molecular Imaging

An automated voxelized dosimetry tool for radionuclide therapy based on serial quantitative SPECT/CT imaging

Price A Jackson, Jean-Mathieu Beauregard, Michael S Hofman, Tomas Kron, Annette Hogg, Rodney J Hicks

Journal article  |  2013  |  Medical Physics

Evaluating the place of 18-fluoro-2-deoxy-D-glucose positron emission tomography scanning in primary staging and beyond in patients with follicular lymphoma

John F Seymour, Judith Trotman, Michael S Hofman

Journal article  |  2013  |  Leukemia and Lymphoma

Breast cancer: Role of planar, SPECT and PET in imaging bone metastases

MS Hofman, RJ Hicks

Book Chapter  |  2013

Thyroid nodules: time to stop over-reporting normal findings and update consensus guidelines

Michael S Hofman

Journal article  |  2013  |  BMJ

High FDG activity in focal fat necrosis: a pitfall in interpretation of posttreatment PET/CT in patients with non-Hodgkin lymphoma

Raghava Kashyap, Eddie Lau, Anupkumar George, John F Seymour, Stephen Lade, Rodney J Hicks, Michael S Hofman

Journal article  |  2013  |  European Journal of Nuclear Medicine and Molecular Imaging

Radiotherapy of abdomen with precise renal assessment with SPECT/CT imaging (RAPRASI): design and methodology of a prospective trial to improve the understanding of kidney radiation dose response

Juanita Lopez-Gaitan, Martin A Ebert, Peter Robins, Jan Boucek, Trevor Leong, David Willis, Sean Bydder, Peter Podias, Gemma Waters, Brenton O'Mara, Julie Chu, Jessica Faggian, Luke Williams, Michael S Hofman, Nigel A Spry

Journal article  |  2013  |  BMC Cancer

Limited role for surveillance PET-CT scanning in patients with diffuse large B-cell lymphoma in complete metabolic remission following primary therapy

CY Cheah, MS Hofman, M Dickinson, A Wirth, D Westerman, SJ Harrison, K Burbury, M Wolf, H Januszewicz, K Herbert, HM Prince, DA Carney, DS Ritchie, RJ Hicks, JF Seymour

Journal article  |  2013  |  British Journal of Cancer

Evaluation of a new visual uptake scoring scale for F-18-fluorothymidine positron emission tomography in the diagnosis of pulmonary lesions

Jean-Mathieu Beauregard, Anne-Laure Giraudet, Nicolas Aide, Michael S Hofman, Robert Blum, Elizabeth Drummond, Peter Roselt, Rodney J Hicks

Journal article  |  2013  |  Nuclear Medicine Communications

International Validation Study for Interim PET in ABVD-Treated, Advanced-Stage Hodgkin Lymphoma: Interpretation Criteria and Concordance Rate Among Reviewers

Alberto Biggi, Andrea Gallamini, Stephane Chauvie, Martin Hutchings, Lale Kostakoglu, Michele Gregianin, Michel Meignan, Bogdan Malkowski, Michael S Hofman, Sally F Barrington

Journal article  |  2013  |  Journal of Nuclear Medicine

Not-So-Random Errors: Randomized Controlled Trials Are Not the Only Evidence of the Value of PET-Rebuttal

Rodney J Hicks, Michael S Hofman, Robert E Ware

Journal article  |  2013  |  Journal of Nuclear Medicine

Let's Get SEERious: More Accurate Staging With Consequent High Management Impact Is Not Just Stage Migration

Michael S Hofman, David L Ball, Michael P Mac Manus, Robert Ware, Rodney J Hicks

Journal article  |  2013  |  Journal of Clinical Oncology

Improving Diagnosis of Tumor-Induced Osteomalacia With Gallium-68 DOTATATE PET/CT

Roderick J Clifton-Bligh, Michael S Hofman, Emma Duncan, Ie-Wen Sim, David Darnell, Adele Clarkson, Tricia Wong, John P Walsh, Anthony J Gill, Peter R Ebeling, Rodney J Hicks

Journal article  |  2013  |  Journal of Clinical Endocrinology & Metabolism

Is there still a role for SPECT-CT in oncology in the PET-CT era?

Rodney J Hicks, Michael S Hofman

Journal article  |  2012  |  Nature Reviews Clinical Oncology

Not-So-Random Errors: Randomized Controlled Trials Are Not the Only Evidence of the Value of PET

Rodney J Hicks, Robert E Ware, Michael S Hofman

Journal article  |  2012  |  Journal of Nuclear Medicine

Changing Paradigms with Molecular Imaging of Neuroendocrine Tumors

Michael S Hofman, Rodney J Hicks

Journal article  |  2012  |  Discovery Medicine

Special delivery: getting radiation to the target in diffuse large B-cell lymphoma

Andrew Wirth, Michael S Hofman

Journal article  |  2012  |  Leukemia and Lymphoma

Fluorodeoxyglucose positron emission tomography/computed tomography for evaluation of bone marrow involvement in lymphoma: when is it superior to biopsy?

Michael S Hofman

Journal article  |  2012  |  Leukemia and Lymphoma

High management impact of Ga-68 DOTATATE (GaTate) PET/CT for imaging neuroendocrine and other somatostatin expressing tumours

Michael S Hofman, Grace Kong, Oliver C Neels, Peter Eu, Emily Hong, Rodney J Hicks

Journal article  |  2012  |  Journal of Medical Imaging and Radiation Oncology

The potential for induction peptide receptor chemoradionuclide therapy to render inoperable pancreatic and duodenal neuroendocrine tumours resectable

TW Barber, MS Hofman, BNJ Thomson, RJ Hicks

Journal article  |  2012  |  European Journal of Surgical Oncology

How to Treat Neuroendocrine Tumours

MS Hofman, M Michael, BN Thomson, RJ Hicks

Journal article  |  2012  |  Australian Doctor

The tumour sink effect on the biodistribution of Ga-68-DOTA-octreotate: implications for peptide receptor radionuclide therapy

Jean-Mathieu Beauregard, Michael S Hofman, Grace Kong, Rodney J Hicks

Journal article  |  2012  |  European Journal of Nuclear Medicine and Molecular Imaging

Ga-68 PET/CT Ventilation-Perfusion Imaging for Pulmonary Embolism: A Pilot Study with Comparison to Conventional Scintigraphy

Michael S Hofman, Jean-Mathieu Beauregard, ThomasW Barber, Oliver C Neels, Peter Eu, Rodney J Hicks

Journal article  |  2011  |  Journal of Nuclear Medicine

Quantitative Lu-177 SPECT (QSPECT) imaging using a commercially available SPECT/CT system

Jean-Mathieu Beauregard, Michael S Hofman, Jucilene M Pereira, Peter Eu, Rodney J Hicks

Journal article  |  2011  |  Cancer Imaging

Imaging in follicular NHL

MS Hofman, RJ Hicks

Journal article  |  2011  |  Best Practice & Research: Clinical Haematology

White fat, factitious hyperglycemia, and the role of FDG PET to enhance understanding of adipocyte metabolism

Michael S Hofman, Rodney J Hicks

Journal article  |  2011  |  EJNMMI Research

Restaging: Should We PERCIST Without Pattern Recognition?

Michael S Hofman, Rodney J Hicks

Journal article  |  2010  |  Journal of Nuclear Medicine

Breast lymphatic drainage via the pulmonary lymphatic system

Thomas W Barber, Michael S Hofman, Rodney J Hicks

Journal article  |  2010  |  European Journal of Nuclear Medicine and Molecular Imaging

Using positron emission tomography to assess tumor proliferation in non-Hodgkin lymphoma

Michael S Hofman, Rodney J Hicks

Journal article  |  2010  |  Leukemia and Lymphoma

The role of chemotherapeutic drugs in the evaluation of breast tumour response to chemotherapy using serial FDG-PET

Michal E Schneider-Kolsky, Stewart Hart, Jane Fox, Peter Midolo, John Stuckey, Michael Hofman, Vinod Ganju

Journal article  |  2010  |  Breast Cancer Research

Observer Variation in Interpreting F-18-FDG PET/CT Findings for Lymphoma Staging

Michael S Hofman, Nigel C Smeeton, Sheila C Rankin, Tom Nunan, Michael J O'Doherty

Journal article  |  2009  |  Journal of Nuclear Medicine

Observer variation in FDG PET-CT for staging of non-small-cell lung carcinoma

Michael S Hofman, Nigel C Smeeton, Sheila C Rankin, Tom Nunan, Michael J O'Doherty

Journal article  |  2009  |  European Journal of Nuclear Medicine and Molecular Imaging

Routine positron emission tomography and positron emission tomography/computed tomography in melanoma staging with positive sentinel node biopsy is of limited benefit

Anastasia Constantinidou, Michael Hofman, Michael O'Doherty, Katharine M Acland, Ciaran Healy, Mark Harries

Journal article  |  2008  |  Melanoma Research

Positron emission tomography (PET) is increasingly used for the staging and management of melanoma. The aim of this study was to e..

How do we best balance optimal timing of FDG PET-CT imaging?

Michael S Hofman, Michael O'Doherty

Journal article  |  2007  |  Nuclear Medicine Communications

Assessing response to chemotherapy in metastatic melanoma with FDG PET: Early experience

Michael S Hofman, Anastasia Constantinidou, Katharine Acland, Ciaran Healy, Mark Harries, Michael O'Doherty

Journal article  |  2007  |  Nuclear Medicine Communications

Meningeal recurrence of intravascular large B-cell lymphoma: early diagnosis with PET-CT.

Michael S Hofman, Paul Fields, Lynny Yung, N George Mikhaeel, Robin Ireland, Tom Nunan

Journal article  |  2007  |  British Journal of Haematology

False-negative myocardial perfusion scintigraphy possibly as a result of administration of low-molecular-weight heparin

Michael S Hofman, Craig Keighley, Victor S Wayne, Steve White, Nathan Better

Journal article  |  2007  |  Clinical Nuclear Medicine

Efficacy of milk versus water to reduce interfering infracardiac activity in Tc-99m-sestamibi myocardial perfusion scintigraphy

Michael Hofman, John McKay, Dee Nandurkar

Journal article  |  2006  |  Nuclear Medicine Communications

OBJECTIVE: Interference from infra-cardiac radionuclide activity prevents accurate interpretation of true myocardial perfusion. Th..